Android app on Google Play

Bio-Reference Labs (BRLI) Reports In-Line Q4 EPS of 46c

December 6, 2012 8:31 AM EST Send to a Friend
Bio-Reference Labs (NASDAQ: BRLI) reported Q4 EPS of $0.46, in-line with the analyst estimate of $0.46. Revenue for the quarter came in at $176.05 million versus the consensus estimate of $175.46 million.

For earnings history and earnings-related data on Bio-Reference Labs (BRLI) click here.




You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment